about
Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivoKruppel-like factor 15 is critical for vascular inflammationRole of coronin 1B in PDGF-induced migration of vascular smooth muscle cellsThe knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human diseaseNeuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferationOverexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progressionPhospholipase C signaling and calcium influxIntrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic SclerosisUnexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migrationIQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injuryDifferential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contractionHistone deacetylase-1 is enriched at the platelet-derived growth factor-D promoter in response to interleukin-1beta and forms a cytokine-inducible gene-silencing complex with NF-kappab p65 and interferon regulatory factor-1Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injuryIncreased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoterRole of platelet-derived growth factors in physiology and medicineAtherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain.Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation.PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality.Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload.Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome XEssential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migrationTetrahydrobiopterin Inhibits PDGF-stimulated Migration and Proliferation in Rat Aortic Smooth Muscle Cells via the Nitric Oxide Synthase-independent Pathway.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method.Effect of substrate stiffness and PDGF on the behavior of vascular smooth muscle cells: implications for atherosclerosisDysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production.PDGFRβ signaling regulates mural cell plasticity and inhibits fat development.Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients.Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation.Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo.Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Mechanical stretch increases MMP-2 production in vascular smooth muscle cells via activation of PDGFR-β/Akt signaling pathway.
P2860
Q24306656-8C09DE1B-7DC4-44CB-A25E-31C8CF569CA7Q24321728-35261D71-5C00-4FDF-9773-BA6DF948C575Q24329111-10CDF767-A2B4-4667-985A-482D6F6F71B1Q24606673-A1CB44E8-3337-4EE5-BA74-B5D0E9E55290Q24647879-E57E6EDE-6472-45C3-9489-3C601A58334DQ24677863-1D37E083-F3C1-4F19-B582-3C2E62154637Q24813774-132AF390-C989-4F63-92DC-E5FDF6ED96DAQ26829051-CF796A61-F4CF-4199-9F09-FD8D604EB5A7Q28551230-35D0F966-A5D7-49E5-9EC0-CBE7682AA13EQ28565782-631CD798-9A33-4E0B-8728-F0FA88F68378Q28568374-F29A9864-DD94-438A-AA92-3BD98BC190BBQ28569329-F6800468-523B-44AD-9D2F-39268684C00CQ28570860-8532B760-EB6B-4B09-82E8-32F27CC41ECDQ28580309-E52ED9D1-AC69-4884-A929-E0A74BCF48E3Q28581716-0FF15F44-914D-4664-BBE5-B18CA1E64939Q29615222-B66CF04C-3AD6-4A62-B374-DA8468E96454Q30416293-867E1ABD-0E17-4BA3-9D8F-ECCA8296CE46Q30419933-152AA0ED-127D-40F9-B8A8-8BD039BAE8BBQ30425676-DDF7C26A-B045-46C7-AE18-226791AE66EDQ30436555-6D132800-C368-4CBD-A507-11089716B158Q30666915-F1807186-E85A-4B87-B4D2-768AD8CD0EF9Q33559670-8DC245A9-4261-4E70-96DF-B9414A2E7781Q33720170-EE3AD23B-C091-49EF-ADE5-4E1FCE3AF0A3Q33781870-291F9B7B-A919-4F82-8D01-AA5F833F0488Q33840443-B6F079D1-B5D0-4E21-86A0-0D02BCCFA3AEQ33988364-A858F141-D17B-4D69-87E6-4A6CC3D5F9B8Q34002877-2D449194-0A8D-4040-A096-1AA558708FE5Q34004655-F5EC6246-4545-4E84-812A-319807F2BB1DQ34060911-26997E5E-A0CC-42E9-86B2-865ED898FF2EQ34137840-8C684CB4-CD8A-47B4-9FBA-FC36FE18B496Q34191687-7F025EE3-EEC6-41DB-9B34-7C0A665478D0Q34349858-F8A2DB7A-38F0-4762-8C1B-9D166051028EQ34352802-4F9129E2-9527-47F8-B761-42B7B05939E7Q34460553-CE777032-BA7A-4A67-AFEE-27E29AF53A6FQ34542793-7920DB6B-144E-4E4D-AF87-93978DF32659Q34550096-771CFD0A-3E17-46DB-ABD4-52896FE9DED7Q34558029-EEBC8E63-F7B1-4A93-ABEA-6C05A9C58CC9Q34606581-7BC36705-9EAB-441D-8DB6-E2EEE6329E50Q34897476-F764B33C-A2A9-404A-B193-0A18C6BDD085Q34946905-3D32F94E-2B35-4166-9108-A9AAF12D8034
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
PDGF and cardiovascular disease.
@ast
PDGF and cardiovascular disease.
@en
type
label
PDGF and cardiovascular disease.
@ast
PDGF and cardiovascular disease.
@en
prefLabel
PDGF and cardiovascular disease.
@ast
PDGF and cardiovascular disease.
@en
P1476
PDGF and cardiovascular disease.
@en
P2093
Elaine W Raines
P304
P356
10.1016/J.CYTOGFR.2004.03.004
P577
2004-08-01T00:00:00Z